Michael J. Nemeth, Ph.D.
Affiliations: | 2001 | Dartmouth College, Hanover, NH, United States |
Area:
PharmacologyGoogle:
"Michael Nemeth"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Christopher Lowrey | grad student | 2001 | Dartmouth | |
| (Targeted manipulation of beta-globin promoter chromatin structure: Implications for gene therapy of beta-hemoglobinopathies.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Srivastava P, Tzetzo S, Cortes Gomez E, et al. (2019) Inhibition of LSD1 in Myelodysplastic Syndrome Progenitors Restores Differentiation of CD141Hi Conventional Dendritic Cells Blood. 134: 1695-1695 |
| Nemeth MJ, Lowrey CH. (2004) An Erythroid-Specific Chromatin Opening Element Increases β-Globin Gene Expression from Integrated Retroviral Gene Transfer Vectors. Gene Therapy & Molecular Biology. 8: 475-486 |
| Pal S, Nemeth MJ, Bodine D, et al. (2004) Neurokinin-B transcription in erythroid cells: direct activation by the hematopoietic transcription factor GATA-1. The Journal of Biological Chemistry. 279: 31348-56 |
| Kitareewan S, Pitha-Rowe I, Sekula D, et al. (2002) UBE1L is a retinoid target that triggers PML/RARalpha degradation and apoptosis in acute promyelocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America. 99: 3806-11 |
| Nemeth MJ, Bodine DM, Garrett LJ, et al. (2001) An erythroid-specific chromatin opening element reorganizes beta-globin promoter chromatin structure and augments gene expression. Blood Cells, Molecules & Diseases. 27: 767-80 |
| McInerney JM, Nemeth MJ, Lowrey CH. (2000) Erythropoiesis: Review Article: Slow and Steady Wins The Race? Progress in the Development of Vectors for Gene Therapy of beta-Thalassemia and Sickle Cell Disease. Hematology (Amsterdam, Netherlands). 4: 437-455 |
| Mcinerney JM, Nemeth MJ, Lowrey CH. (1999) Slow and Steady Wins The Race? Progress in the Development of Vectors for Gene Therapy of β-Thalassemia and Sickle Cell Disease. Hematology (Amsterdam, Netherlands). 4: 437-55 |
| Iler N, Goodwin AJ, McInerney J, et al. (1999) Targeted remodeling of human beta-globin promoter chromatin structure produces increased expression and decreased silencing. Blood Cells, Molecules & Diseases. 25: 47-60 |
| Hamilton JW, Kaltreider RC, Bajenova OV, et al. (1998) Molecular basis for effects of carcinogenic heavy metals on inducible gene expression. Environmental Health Perspectives. 106: 1005-15 |